Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus

Lupus

Volumn 17, Issue 12, 2008, Pages 1103-1107

  Mok, C C ^a   Cheung, M Y ^a   Ho, L Y ^a   Yu, K L ^a   To, C H ^a  

^a POK OI HOSPITAL   (Hong Kong)

Author keywords

Damage; Lupus; Morbidity; Socioeconomic; Unemployment

Indexed keywords

ADULT; ANXIETY; ARTICLE; CHINESE; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE DURATION; EMPLOYMENT STATUS; FATIGUE; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; JOB PERFORMANCE; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MEMORY DISORDER; MUSCULOSKELETAL PAIN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; WORK DISABILITY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DISABILITY EVALUATION; EMPLOYMENT; FEMALE; HONG KONG; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MORBIDITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; UNEMPLOYMENT;

EID: 60349090688     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308094280     Document Type: Article

References (12)

1. Mok, CC. Emerging drug therapies for systemic lupus erythematosus. Expert Opin Emerg Drugs 2006; 11: 597-608.
2. Meller, S, Homey, B, Ruzicka, T. Socioeconomic factors in lupus erythematosus. Autoimmun Rev 2005; 4: 242-246.
3. Yelin, E, Cisternas, MG, Pasta, DJ, Trupin, L, Murphy, L, Helmick, CG. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: Total and incremental estimates. Arthritis Rheum 2004; 50: 2317-2326.
4. Yelin, E, Trupin, L, Katz, P, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 56-63.
5. Panopalis, P, Julian, L, Yazdany, J, et al. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 1453-1460.
6. Bertoli, AM, Fernández, M, Alarcón, GS, Vilá, LM, Reveille, JD. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): Factors predictive of self-reported work disability. Ann Rheum Dis 2007; 66: 12-17.
7. Utset, TO, Fink, J, Doninger, NA. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 531-538.
8. Partridge, AJ, Karlson, EW, Daltroy, LH, et al. Risk factors for early work disability in systemic lupus erythematosus: Results from a multicenter study. Arthritis Rheum 1997; 40: 2199-2206.
9. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
10. Cella, D, Yount, S, Sorensen, M, Chartash, E, Sengupta, N, Grober, J, et al. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 811-819.
11. Gladman, D, Ginzler, E, Goldsmith, C, et al. The development and initial validation of the systemic lupus international collaborating clinics/ American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
12. Buyon, JP, Petri, MA, Kim, MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial. Ann Intern Med 2005; 142: 953-962.